1. Market Overview
1.1 Introduction
Table 1: Types of Electrical Stimulation For Chronic Pain
1.2 Spinal Cord Stimulation Devices
1.3 Conditions for SCS Treatment
1.4 Spinal Cord Stimulation Therapies
1.5 Surgical Procedures
2. Global Spinal Cord Stimulation (SCS) Market
2.1 Global SCS Market Forecast by Value
Table 2: Global SCS Market Forecast by Value (2016-2021)
2.2 Global SCS Market by Region
Table 3: Global SCS Market by Region (2016)
2.3 Global SCS Addressable Population Forecast
Table 4: Global SCS Addressable Population Forecast (2016-2021)
2.4 Global SCS System Implant Volume Forecast
Table 5: Global SCS System Implant Volume Forecast (2016-2021)
3. Regional Market
3.1 The U.S.
3.1.1 The U.S. Chronic Back Pain Prevalence Forecast
Table 6: The U.S. Chronic Back Pain Prevalence Forecast (2016-2021)
3.1.2 The U.S. SCS Market Forecast by Value
Table 7: The U.S. SCS Market Forecast by Value (2016-2021)
3.1.3 The U.S. Addressable SCS Population Forecast
Table 8: The U.S. Addressable SCS Population Forecast (2016-2021)
3.1.4 The U.S. SCS System Implant Volume Forecast
Table 9: The U.S. SCS System Implant Volume Forecast (2016-2021)
3.2 Outside the U.S.
3.2.1 Outside the U.S. SCS Market Forecast by Value
Table 10: OUS SCS Market Forecast by Value (2016-2021)
3.2.2 Outside the U.S. SCS Addressable Population Forecast
Table 11: OUS SCS Addressable Population Forecast (2016-2021)
3.2.3 Outside the U.S. SCS System Implant Volume Forecast
Table 12: OUS SCS System Implant Volume Forecast (2016-2021)
3.2.4 Outside the U.S. Rechargeable SCS Market Forecast by Value
Table 13: OUS Rechargeable SCS Market Forecast by Value (2016-2021)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Ageing Population
Table 14: Global Ageing Population (2012-2016)
4.1.2 Increasing Healthcare Spending
Table 15: Global Healthcare Spending Per Capita (2012-2016)
4.1.3 Rising GDP Per Capita
Table 16: Global GDP Per Capita (2012-2016)
4.1.4 Increase in Obese Population
Table 17: Global Obese Population (2012-2016)
4.2 Key Trends & Developments
4.2.1 Increase in Trial Units for SCS in the U.S.
Table 18: Increase Trial Units for SCS in the U.S. (2016-2021)
4.2.2 Mergers and Acquisitions
Table 19: Mergers and Acquisitions (2016-2017)
4.2.3 Increasing SCS Implants for Predominant Back Pain in the U.S.
Table 20: The U.S. SCS Implant Volume by Pain Location (2016)
4.2.4 Accelerating Use of Percutaneous Lead Technology in SCS Treatments
Table 21: The U.S. (2016)
Table 22: Outside the U.S. (2016)
4.2.5 Increasing Demand for Minimally Invasive Devices
4.2.6 Rising Awareness of Early Treatment for Chronic Pain
4.2.7 New Product Launches
4.2.8 Burden of Chronic Pain in the U.S.
4.2.9 Favorable Reimbursement Policies in the U.S.
4.3 Challenges
4.3.1 Dependence on Traditional Therapies
4.3.2 High Cost Related to SCS Treatment
4.3.3 Tough Regulatory Problems
5. Competitive Landscape
5.1 Global SCS Market
5.1.1 Revenue and Market Cap Comparison
Table 23: Key Players - Revenue & Market Cap Comparison (2016)
5.1.2 Global SCS Market Share by Company
Table 24: Global SCS Market Share by Company (2016/2020E)
5.1.3 Key SCS Product Comparison by Company
Table 25: Key SCS Product Comparison by Company (2016)
5.2 Regional SCS Market
5.2.1 The U.S. SCS Market Share by Company
Table 26: The U.S. SCS Market Share by Company (2016)
5.2.2 Outside the U.S. SCS Market Share by Company
Table 27: Outside the U.S. SCS Market Share by Company (2016)
6. Company Profiles
6.1 Nevro Corporation
6.1.1 Business Overview
Table 28: Nevro Corporation Revenue by Region (2016)
6.1.2 Financial Overview
Table 29: Nevro Corporation Revenue and Net Loss (2012-2016)
6.1.3 Business Strategies
Table 30: Nevro Corporation R&D Expenditure (2012-2016)
6.2 Medtronic Plc
6.2.1 Business Overview
Table 31: Medtronic Plc Revenue by Segment (2017*)
6.2.2 Financial Overview
Table 32: Medtronic Plc Net Revenue and Net Profit (2013-2017*)
6.2.3 Business Strategies
6.3 Boston Scientific
6.3.1 Business Overview
Table 33: Boston Scientific Revenue by Segment (2016)
6.3.2 Financial Overview
Table 34: Boston Scientific’s Revenue and Annual Growth (2012-2016)
6.3.3 Business Strategies
6.4 Abbott Laboratories (St. Jude Medical)
6.4.1 Business Overview
Table 35: Abbott Laboratories Revenue by Segment (2016)
6.4.2 Financial Overview
Table 36: Abbott Laboratories Revenue and Net Income (2012-2016)
6.4.3 Business Strategies
Table 37: Abbott Laboratories R&D Expenditure (2012-2016)herapy Device Market Share Ranking by Segment, U.S., 2017
Figure 1 2: Companies Researched in this Report, U.S., 2017
Figure 1 3: Factors Impacting the Infusion Therapy Devices Market by Segment, U.S.
Figure 1 4: Recent Events in the Infusion Therapy Devices Market, U.S., 2013 – 2017
Figure 1 5: Infusion Therapy Devices Markets Covered, U.S., 2017
Figure 1 6: Key Report Updates
Figure 1 7: Version History
Figure 2 1: Infusion Therapy Devices Market by Segment, U.S., 2014 – 2024 (US$M)
Figure 2 2: Infusion Therapy Device Market Growth by Segment, U.S., 2014 – 2024
Figure 2 3: Drivers and Limiters, Infusion Therapy Device Market, U.S., 2017
Figure 2 4: Leading Competitors, Infusion Therapy Device Market, U.S., 2017
Figure 3 1: Hospital Statistics, U.S., 2014 – 2024
Figure 3 2: Pump Penetration Rates, U.S., 2014 – 2024
Figure 3 3: Infusion Pump Market by Segment, U.S., 2014 – 2024 (US$M)
Figure 3 4: Large Volume Infusion Pump Market, U.S., 2014 – 2024
Figure 3 5: Large Volume Infusion Pump Market by Care Setting, U.S., 2014 – 2024
Figure 3 6: Acute Care Market, U.S., 2014 – 2024
Figure 3 7: Alternate Care Market, U.S., 2014 – 2024
Figure 3 8: Large Volume Infusion Pump Market by Channels, U.S., 2014 – 2024
Figure 3 9: Single Channel Pump Market, U.S., 2014 – 2024
Figure 3 10: Multi-Channel Pump Market, U.S., 2014 – 2024
Figure 3 11: Syringe Infusion Pump Market, U.S., 2014 – 2024
Figure 3 12: Syringe Infusion Pump Market by Care Setting, U.S., 2014 – 2024
Figure 3 13: Acute Care Market, U.S., 2014 – 2024
Figure 3 14: Alternate Care Market, U.S., 2014 – 2024
Figure 3 15: Syringe Infusion Pump Market by Channels, U.S., 2014 – 2024
Figure 3 16: Single Channel Pump Market, U.S., 2014 – 2024
Figure 3 17: Multi-Channel Pump Market, U.S., 2014 – 2024
Figure 3 18: Patient-Controlled Analgesia Infusion Pump Market, U.S., 2014 – 2024
Figure 3 19: Patient-Controlled Analgesia Infusion Pump Market by Care Setting, U.S., 2014 – 2024
Figure 3 20: Acute Care Market, U.S., 2014 – 2024
Figure 3 21: Alternate Care Market, U.S., 2014 – 2024
Figure 3 22: Electronic Ambulatory Infusion Pump Market, U.S., 2014 – 2024
Figure 3 23: Disposable Ambulatory Infusion Pump Market, U.S., 2014 – 2024
Figure 3 24: Disposable Ambulatory Infusion Pump by Type, U.S., 2014 – 2024
Figure 3 25: Disposable Ambulatory Infusion Non-Pain Pump Market, U.S., 2014 – 2024
Figure 3 26: Disposable Ambulatory Infusion Pain Pump Market, U.S., 2014 – 2024
Figure 3 27: Disposable Ambulatory Infusion Pain Pump by Type, U.S., 2014 – 2024
Figure 3 28: Disposable Surgical Post-Operative Pain Pump Market, U.S., 2014 – 2024
Figure 3 29: Disposable Peripheral Nerve Block Pain Pump Market, U.S., 2014 – 2024
Figure 3 30: Drivers and Limiters, Infusion Pump Market, U.S., 2017
Figure 3 31: Leading Competitors by Revenue, Infusion Pump Market, U.S., 2017
Figure 3 32: Leading Competitors by Installed Base, Infusion Pump Market, U.S., 2017
Figure 4 1: Intravenous Set Market by Segment, U.S., 2014 – 2024 (US$M)
Figure 4 2: Primary IV Set Market, U.S., 2014 – 2024
Figure 4 3: Primary IV Set by Type, U.S., 2014 – 2024
Figure 4 4: Dedicated Primary IV Set Market, U.S., 2014 – 2024
Figure 4 5: Dedicated Primary IV Set Market by Type, U.S., 2014 – 2024
Figure 4 6: Specialty Set Market, U.S., 2014 – 2024
Figure 4 7: Specialty Set Market by Type, U.S., 2014 – 2024
Figure 4 8: Light Protected IV Sets Market, U.S., 2014 – 2024
Figure 4 9: Total Parenteral Nutrition IV Sets Market, U.S., 2014 – 2024
Figure 4 10: Blood Administration IV Sets Market, U.S., 2014 – 2024
Figure 4 11: Pediatric IV Sets Market, U.S., 2014 – 2024
Figure 4 12: General Ward Primary Set Market, U.S., 2014 – 2024
Figure 4 13: Dedicated Primary IV Set Market, U.S., 2014 – 2024
Figure 4 14: Primary IV Set Market by Setting, U.S., 2014 – 2024
Figure 4 15: Acute Care Market, U.S., 2014 – 2024
Figure 4 16: Alternate Care Market, U.S., 2014 – 2024
Figure 4 17: IV Extension Set Market, U.S., 2014 – 2024
Figure 4 18: IV Extension Set Market by Setting, U.S., 2014 – 2024
Figure 4 19: Acute Care Market, U.S., 2014 – 2024
Figure 4 20: Alternate Care Market, U.S., 2014 – 2024
Figure 4 21: Gravity Set Market, U.S., 2014 – 2024
Figure 4 22: Gravity Set Market by Type, U.S., 2014 – 2024
Figure 4 23: Gravity Administration Set Market, U.S., 2014 – 2024
Figure 4 24: Gravity Transfusion Set Market, U.S., 2014 – 2024
Figure 4 25: Secondary IV Set Market, U.S., 2014 – 2024
Figure 4 26: Secondary IV Set Market by Setting, U.S., 2014 – 2024
Figure 4 27: Acute Care Market, U.S., 2014 – 2024
Figure 4 28: Alternate Care Market, U.S., 2014 – 2024
Figure 4 29: DEHP IV Sets Market, U.S., 2014 – 2024
Figure 4 30: Non-DEHP IV Sets Market, U.S., 2014 – 2024
Figure 4 31: Drivers and Limiters, Intravenous Set Market, U.S., 2017
Figure 4 32: Leading Competitors, Intravenous Set Market, U.S., 2017
Figure 5 1: Needleless Connector Market by Valve Type, U.S., 2014 – 2024 (US$M)
Figure 5 2: Needleless Connector Market by Device Type, U.S., 2014 – 2024 (US$M)
Figure 5 3: Needleless Connector Market by Setting, U.S., 2014 – 2024 (US$M)
Figure 5 4: Total Needleless Connector Market, U.S., 2014 – 2024
Figure 5 5: Split Septum & Blunt Cannula NLC Market, U.S., 2014 – 2024
Figure 5 6: Total Mechanical Valve NLC Market, U.S., 2014 – 2024
Figure 5 7: Mechanical Valve NLC Market by Type, U.S., 2014 – 2024 (US$M)
Figure 5 8: Negative Displacement Mechanical Valve NLC Market, U.S., 2014 – 2024
Figure 5 9: Positive Displacement Mechanical Valve NLC Market, U.S., 2014 – 2024
Figure 5 10: Neutral Displacement Mechanical Valve NLC Market, U.S., 2014 – 2024
Figure 5 11: Anti-Reflux Neutral Displacement Mechanical Valve NLC Market, U.S., 2014 – 2024
Figure 5 12: Standalone NLC Market, U.S., 2014 – 2024
Figure 5 13: Integrated NLC Market, U.S., 2014 – 2024
Figure 5 14: Acute Care Market, U.S., 2014 – 2024
Figure 5 15: Alternate Care Market, U.S., 2014 – 2024
Figure 5 16: Drivers and Limiters, Needleless Connector Market, U.S., 2017
Figure 5 17: Leading Competitors, Needleless Connector Market, U.S., 2017
Figure 6 1: Intravenous Filter Market, U.S., 2014 – 2024
Figure 6 2: Drivers and Limiters, Intravenous Filter Market, U.S., 2017
Figure 6 3: Leading Competitors, Intravenous Filter Market, U.S., 2017
Figure 7 1: Blood Transfusion Market, U.S., 2014 – 2024
Figure 7 2: Drivers and Limiters, Blood Transfusion Market, U.S., 2017
Figure 7 3: Leading Competitors, Blood Transfusion Market, U.S., 2017